Infliximab treatment for Crohn's disease

被引：19

作者：

Conroy, CA ^{[1
]}

Cattell, R ^{[1
]}

机构：

[1] Univ Bristol, Bristol Royal Infirm, Dept Pharm, Bristol BS2 8HW, Avon, England

来源：

POSTGRADUATE MEDICAL JOURNAL | 2001年 / 77卷 / 909期

关键词：

D O I：

10.1136/pmj.77.909.436

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：436 / 440

页数：5

共 43 条

[1] Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis [J].

Baert, FJ ;

D'Haens, GR ;

Peeters, M ;

Hiele, MI ;

Schaible, TF ;

Shealy, D ;

Geboes, K ;

Rutgeerts, PJ .

GASTROENTEROLOGY, 1999, 116 (01) :22-28

[2]

BELL S, 2000, RES CLIN FORUMS, V22, P129

[3] Diagnosis of extraintestinal manifestations and cancers in IBD in large population-based databases. [J].

Bernstein, CN ;

Kliewer, E ;

Rawsthorne, P ;

Doig, W ;

Blanchard, JF .

GASTROENTEROLOGY, 1998, 114 (04) :A930-A931

[4] The relationship between infliximab treatment and lymphoma in Crohn's disease [J].

Bickston, SJ ;

Lichtenstein, GR ;

Arseneau, KO ;

Cohen, RB ;

Cominelli, F .

GASTROENTEROLOGY, 1999, 117 (06) :1433-1437

[5]

*BRIT SOC GASTR, 1996, INFL BOW DIS GUID

[6]

CRAWFORD JM, 1994, ROBBINS PATHOLOGIC B, P801

[7] Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial [J].

D'Haens, G ;

Van Deventer, S ;

Van Hogezand, R ;

Chalmers, D ;

Kothe, C ;

Baert, F ;

Braakman, T ;

Schaible, T ;

Geboes, K ;

Rutgeerts, P .

GASTROENTEROLOGY, 1999, 116 (05) :1029-1034

[8] Thalidomide therapy for patients with refractory Crohn's disease: An open-label trial [J].

Ehrenpreis, ED ;

Kane, SV ;

Cohen, LB ;

Cohen, RD ;

Hanauer, SB .

GASTROENTEROLOGY, 1999, 117 (06) :1271-1277

[9]

EKBOM A, 1991, CANCER-AM CANCER SOC, V67, P2015, DOI 10.1002/1097-0142(19910401)67:7<2015::AID-CNCR2820670731>3.0.CO

[10]

2-R

← 1 2 3 4 5 →